Detalhe da pesquisa
1.
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review.
Oncologist
; 26(11): 950-955, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342086
2.
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour.
Eur Respir J
; 59(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34795035
3.
Computing the Cost of Care per Patient per Day for Patients With Metastatic Neuroendocrine Neoplasms.
JCO Oncol Pract
; 20(2): 203-211, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096469
4.
Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites.
Endocr Relat Cancer
; 29(12): 665-679, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36165930
5.
Rapid Progression After 177Lu-DOTATATE in Patients With Neuroendocrine Tumors.
Pancreas
; 50(6): 890-894, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398071
6.
Examination of factors associated with lymph node metastases in lung carcinoids: Results from a single institution retrospective cohort study.
Lung Cancer
; 154: 186-194, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33551175
7.
PAM staining intensity of primary neuroendocrine neoplasms is a potential prognostic biomarker.
Sci Rep
; 10(1): 10943, 2020 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616904